| scholarly article | Q13442814 |
| P50 | author | Robin Shattock | Q84767097 |
| P2093 | author name string | Naheed Mahmood | |
| Qinxue Hu | |||
| P2860 | cites work | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 |
| Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120 | Q27635270 | ||
| Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides | Q27639344 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| The antigenic structure of the HIV gp120 envelope glycoprotein | Q28274698 | ||
| Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells | Q28288205 | ||
| Proteins that bind high-mannose sugars of the HIV envelope | Q28295811 | ||
| Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp | Q28299555 | ||
| GP120: target for neutralizing HIV-1 antibodies | Q28303124 | ||
| Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1 | Q28646731 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 | Q29619512 | ||
| Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. | Q33648180 | ||
| Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses | Q33804363 | ||
| Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis | Q33813025 | ||
| Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. | Q33842989 | ||
| The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. | Q34341843 | ||
| The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. | Q34342352 | ||
| Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes | Q35024164 | ||
| Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development | Q35137168 | ||
| Inhibiting sexual transmission of HIV-1 infection | Q35709090 | ||
| The entry of entry inhibitors: a fusion of science and medicine | Q35976966 | ||
| Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue | Q36399466 | ||
| Inhibition of HIV entry by carbohydrate-binding proteins | Q36434175 | ||
| Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner | Q38301855 | ||
| Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins. | Q38301990 | ||
| The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors | Q39597685 | ||
| Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 | Q39612212 | ||
| Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. | Q40204965 | ||
| The rational design of an AIDS vaccine | Q40348550 | ||
| Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies | Q40484043 | ||
| Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells | Q42163960 | ||
| An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization | Q43451743 | ||
| Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. | Q44572417 | ||
| Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion | Q45422914 | ||
| Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models | Q45670260 | ||
| Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization | Q46553841 | ||
| The C-type lectin superfamily in the immune system | Q46835986 | ||
| A role for carbohydrates in immune evasion in AIDS. | Q47982875 | ||
| A general model for the surface glycoproteins of HIV and other retroviruses. | Q49281404 | ||
| Isolation and characterization of a lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis ) bulbs | Q61551531 | ||
| Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41 | Q73097938 | ||
| Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques | Q73814670 | ||
| Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV | Q81410989 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 145-154 | |
| P577 | publication date | 2007-07-23 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization | |
| P478 | volume | 368 |
| Q39152233 | "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches. |
| Q37192185 | A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN. |
| Q38343814 | Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope |
| Q34291727 | Algal lectins as potential HIV microbicide candidates |
| Q38121588 | Algal lectins as promising biomolecules for biomedical research |
| Q38868608 | Antiviral Activity of Synthetic Aminopyrrolic Carbohydrate Binding Agents: Targeting the Glycans of Viral gp120 to Inhibit HIV Entry. |
| Q38260235 | Antiviral drug discovery: broad-spectrum drugs from nature |
| Q36492955 | Carbohydrate recognition by the antiviral lectin cyanovirin-N. |
| Q40743773 | Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro. |
| Q35195445 | Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity |
| Q38196457 | Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition |
| Q93020607 | Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV Envelope |
| Q28263932 | Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies |
| Q38884170 | Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention |
| Q58555325 | HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins |
| Q38291704 | HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): an overview. |
| Q28086826 | HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth |
| Q52341775 | Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins. |
| Q83111898 | Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction |
| Q39830543 | Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility |
| Q43095098 | Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies |
| Q38292980 | Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor |
| Q36107520 | Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin |
| Q37208595 | Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN. |
| Q33625151 | Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. |
| Q40168596 | NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles |
| Q37767654 | Potential of carbohydrate-binding agents as therapeutics against enveloped viruses |
| Q30353580 | Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 |
| Q34674715 | Retracted: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells |
| Q37056391 | Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processing |
| Q35415972 | Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women. |
| Q35677448 | Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission |
| Q42602929 | Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose |
| Q38239575 | Targeting strategies for delivery of anti-HIV drugs |
| Q37036454 | The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism |
| Q35604541 | The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry |
| Q30356350 | The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop. |
| Q39224771 | The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents |
| Q35031133 | Topical prophylaxis for HIV prevention in women: becoming a reality |
| Q39385021 | Transformation of Althaea officinalis L. by Agrobacterium rhizogenes for the production of transgenic roots expressing the anti-HIV microbicide cyanovirin-N. |
Search more.